Shares of Prana Tumble +71.5% After PBT2 Misses Endpoints

By: via Benzinga
Shares of Prana Biotechnology Limited (NASDAQ: PRAN) fell more than 71.5% following a miss in preliminary results of Phase 2 IMAGINE ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.